1 Product identity
Ingredient risk
2 ingredients to use with caution

Bone Health

BrandAmvilabOther Combinations Tablet or Pill 4 ingredients 2 caution DSLD #298136
Net contents: 120 Tablet(s)
Target: Adult (18 - 50 Years)
DSLD entry: 2023-09-25
2 Ingredients (4)
IngredientGroupSafety
Vitamin D3Vitamin D3Use with Caution
CalciumCalciumConditionally Safe
MagnesiumMagnesiumUse with Caution
Trace mineral blendTrace mineral blend
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
⚠️ Use with caution — restricted in some markets
Vitamin D — Granulomatous diseases (sarcoidosis, TB) — unregulated extra-renal CYP27B1 can cause life-threatening hypercalcemia even at standard doses [2][21]
Magnesium — Severe deficiency (<0.50 mmol/L) causes secondary hypocalcemia and hypokalemia that will not correct until magnesium is repleted first [1].
3 Safety cross-reference
Vitamin D — Use with Caution
⚠ Hypercalcemia at >10,000 IU/day
⚠ Vascular calcification risk
Calcium — Conditionally Safe
⚠ Cardiovascular risk debated >1,000 mg/day
⚠ Kidney stones
Magnesium — Use with Caution
⚠ Diarrhea (especially oxide)
⚠ Accumulates in renal impairment
4 Label claims
• Nutrient
• All Other
• Structure/Function
5 Data source
DSLD ID298136
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2023-09-25
6 More from Amvilab
View Amvilab Safety Scorecard → 78 products
Acne FormulaAlpha Lipoic Acid 600 mgAmevit KidsApple Cider Vinegar +Apple Cider Vinegar Apple FlavoredBeauty MultiVite Lemon Flavored
7 Cite this page
Vancouver
Pkhakadze G. Bone Health — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Jun 24]. Available from: https://supplement.ge/products/bone-health-298136/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG